Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hart-Scott-Rodino Antitrust Improvements Act

This article was originally published in The Gray Sheet

Executive Summary

Firms will likely be able to electronically file premerger notification submissions by early 2006, Marian Bruno, Federal Trade Commission pre-merger notification and operations assistant director said Nov. 15 at a Food & Drug Law Institute conference in Washington, D.C. Meanwhile, FTC and the Department of Justice's Antitrust Division are reviewing comments on proposed changes to the Hart-Scott-Rodino rules that would allow firms filing premerger documents to provide Internet links to certain documents, including annual reports and SEC filings, in lieu of paper copies. The proposal would also require a company that does not respond to a second request for additional information regarding its premerger filing for 18 months to file a new submission...

You may also be interested in...

OTC Marketing Awards Just Two Weeks Away

This year's OTC Marketing Awards is celebrating innovation and creativity in the British consumer healthcare industry.

US FDA Pharmaceutical Quality Office Lauds Continuous Manufacturing Approvals

The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.

Warning Letter Roundup & Recap – 19 February 2020

No device-related warning letters were released by the US FDA the week of 19 February.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts